You are here:
Home
NICE Guidance
Conditions and diseases
Cancer
Breast cancer
Henlius (pertuzumab biosimilar) for treating HER2-positive breast cancer [TS ID 12094]
Topic selection
Project information
Project documents
36177-Pertuzumab-Biosimilar-for-Breast-Cancer-V1.0-JUL2024-NON-CONF.pdf (nihr.ac.uk)
Back to top